Serum Neurofilament Light Chain as a Marker of Progression in Parkinson’s Disease: Long-Term Observation and Implications of Clinical Subtypes

BACKGROUND: Biochemical and clinical biomarkers correlate with progression rate and disease severity in Parkinson’s disease (PD) but are not sufficiently studied in late PD. OBJECTIVE: To examine how serum neurofilament light chain (S-NfL) alone or combined with clinical classifications predicts PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Ygland Rödström, Emil, Mattsson-Carlgren, Niklas, Janelidze, Shorena, Hansson, Oskar, Puschmann, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925110/
https://www.ncbi.nlm.nih.gov/pubmed/34806619
http://dx.doi.org/10.3233/JPD-212866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925110/
https://www.ncbi.nlm.nih.gov/pubmed/34806619
http://dx.doi.org/10.3233/JPD-212866

Ejemplares similares